Leapfrog Micro-Infusion Device
Payments companies reported to CMS as associated with Leapfrog Micro-Infusion Device. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Leapfrog Micro-Infusion Device, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Leapfrog Micro-Infusion Device
These are the largest totals companies reported as associated with Leapfrog Micro-Infusion Device. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Paul Gagne | Darien, CT | Vascular Surgery | $1,050.54 |
| Erin Murphy | Charlotte, NC | Vascular Surgery | $224.84 |
| David Dexter | Norfolk, VA | Vascular Surgery | $220.81 |
| Mahmood Razavi | Orange, CA | Vascular & Interventional Radiology | $138.32 |
| James Leiter | Lebanon, NH | Pulmonary Disease | $77.34 |
| Jake Hemingway | Seattle, WA | Vascular Surgery | $68.52 |
| Miguel Montero | Houston, TX | Vascular & Interventional Radiology | $53.73 |
| Craig Walker | Houma, LA | Interventional Cardiology | $53.73 |
| Venita Chandra | Palo Alto, CA | Vascular Surgery | $52.35 |
| Raghu Kolluri | Columbus, OH | Internal Medicine | $52.35 |
Prescribed Leapfrog Micro-Infusion Device?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.